316 related articles for article (PubMed ID: 18473883)
1. Inhibition of efflux of quinolines as new therapeutic strategy in malaria.
Henry M; Alibert S; Rogier C; Barbe J; Pradines B
Curr Top Med Chem; 2008; 8(7):563-78. PubMed ID: 18473883
[TBL] [Abstract][Full Text] [Related]
2. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
[TBL] [Abstract][Full Text] [Related]
3. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
van Schalkwyk DA; Egan TJ
Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
[TBL] [Abstract][Full Text] [Related]
4. Quinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P. falciparum.
Hrycyna CA; Summers RL; Lehane AM; Pires MM; Namanja H; Bohn K; Kuriakose J; Ferdig M; Henrich PP; Fidock DA; Kirk K; Chmielewski J; Martin RE
ACS Chem Biol; 2014 Mar; 9(3):722-30. PubMed ID: 24369685
[TBL] [Abstract][Full Text] [Related]
5. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
[TBL] [Abstract][Full Text] [Related]
6. Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran.
Ursing J; Zakeri S; Gil JP; Björkman A
Acta Trop; 2006 Mar; 97(3):352-6. PubMed ID: 16490179
[TBL] [Abstract][Full Text] [Related]
7. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum.
Gabryszewski SJ; Modchang C; Musset L; Chookajorn T; Fidock DA
Mol Biol Evol; 2016 Jun; 33(6):1554-70. PubMed ID: 26908582
[TBL] [Abstract][Full Text] [Related]
9. Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter.
Egan TJ; Kuter D
Future Microbiol; 2013 Apr; 8(4):475-89. PubMed ID: 23534360
[TBL] [Abstract][Full Text] [Related]
10. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.
Sanchez CP; Stein WD; Lanzer M
Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873
[TBL] [Abstract][Full Text] [Related]
11. Genetic linkage analyses redefine the roles of PfCRT and PfMDR1 in drug accumulation and susceptibility in Plasmodium falciparum.
Sanchez CP; Mayer S; Nurhasanah A; Stein WD; Lanzer M
Mol Microbiol; 2011 Nov; 82(4):865-78. PubMed ID: 21999470
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine resistance reversal agents as promising antimalarial drugs.
Henry M; Alibert S; Orlandi-Pradines E; Bogreau H; Fusai T; Rogier C; Barbe J; Pradines B
Curr Drug Targets; 2006 Aug; 7(8):935-48. PubMed ID: 16918322
[TBL] [Abstract][Full Text] [Related]
14. Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in
Sanchez CP; Moliner Cubel S; Nyboer B; Jankowska-Döllken M; Schaeffer-Reiss C; Ayoub D; Planelles G; Lanzer M
J Biol Chem; 2019 Aug; 294(34):12766-12778. PubMed ID: 31285265
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter.
Richards SN; Nash MN; Baker ES; Webster MW; Lehane AM; Shafik SH; Martin RE
PLoS Pathog; 2016 Jul; 12(7):e1005725. PubMed ID: 27441371
[TBL] [Abstract][Full Text] [Related]
16. Analysis of P-glycoprotein expression in purified parasite plasma membrane and food vacuole from Plasmodium falciparum.
Elandaloussi LM; Lindt M; Collins M; Smith PJ
Parasitol Res; 2006 Nov; 99(6):631-7. PubMed ID: 16710674
[TBL] [Abstract][Full Text] [Related]
17. Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs.
Mok S; Liong KY; Lim EH; Huang X; Zhu L; Preiser PR; Bozdech Z
Mol Microbiol; 2014 Mar; 91(5):918-34. PubMed ID: 24372851
[TBL] [Abstract][Full Text] [Related]
18. Multiple transporters associated with malaria parasite responses to chloroquine and quinine.
Mu J; Ferdig MT; Feng X; Joy DA; Duan J; Furuya T; Subramanian G; Aravind L; Cooper RA; Wootton JC; Xiong M; Su XZ
Mol Microbiol; 2003 Aug; 49(4):977-89. PubMed ID: 12890022
[TBL] [Abstract][Full Text] [Related]
19. Quinoline antimalarials: mechanisms of action and resistance.
Foley M; Tilley L
Int J Parasitol; 1997 Feb; 27(2):231-40. PubMed ID: 9088993
[TBL] [Abstract][Full Text] [Related]
20. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.
Reed MB; Saliba KJ; Caruana SR; Kirk K; Cowman AF
Nature; 2000 Feb; 403(6772):906-9. PubMed ID: 10706290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
